Sii

India Inches Closer Towards Oxford Vaccine, Panel Recommends DCGI To Permit SII For Human Trials

India Readies 5 Sites For Phase 3 Human Trials Of Oxford Covid-19 Vaccine; SII To Start Manufacturing Next Month